Skip to main content

Table 3 The results of primary and secondary patency rates for different lesions in diabetes group

From: Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial

   6 months 12 months 24 months 36 months
iliac lesions (n = 26) primary patency rate 100% 87.5% ± 6.8% 82.6% ± 7.9% 75.1% ± 10.2%
  secondary patency rate 100% 95.8% ± 4.1% 90.8% ± 6.2% 82.5% ± 9.7%
femoral primary patency rate 88.2% ± 4.5% 73.2% ± 6.4% 67.7% ± 7% 58.6% ± 8.6%
lesions
(n = 51)
secondary patency rate 94.1% ± 3.3% 89.8% ± 4.3% 84.5% ± 5.5% 73.2% ± 7.8%
popliteal primary patency rate 78.9% ± 9.4% 42.1% ± 11.3% 42.1% ± 11.3% 42.1% ± 11.3%
lesions
(n = 19)
secondary patency rate 84.2% ± 8.4% 73.7% ± 10.1% 62.7% ± 11.2% 55.8% ± 11.9%
tibial primary patency rate 75.0% ± 10.8% 53.8% ± 12.9% 30.8% ± 12.5% 30.8% ± 12.5%
lesions
(n = 16)
secondary patency rate 87.5% ± 8.3% 67.3% ± 12% 43.6% ± 13.6% 43.6% ± 13.6%